Insider Transactions in Q2 2025 at Atri Cure, Inc. (ATRC)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2025
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,500
-3.29%
|
$82,500
$33.44 P/Share
|
|
May 19
2025
|
Maggie Yuen Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+27.32%
|
-
|
|
May 19
2025
|
Regina E Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+12.99%
|
-
|
|
May 19
2025
|
Deborah H Telman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+19.58%
|
-
|
|
May 19
2025
|
Sven Wehrwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+13.58%
|
-
|
|
May 19
2025
|
B Kristine Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+9.78%
|
-
|
|
May 19
2025
|
Shlomo Nachman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+22.59%
|
-
|
|
May 19
2025
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+18.86%
|
-
|
|
May 19
2025
|
Robert S. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,401
+4.59%
|
-
|
|
May 05
2025
|
Robert S. White Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.56%
|
$220,000
$22.62 P/Share
|